Xen approved for refractory glaucoma in China

April 9, 2020
China’s National Medical Products Administration approved the use of the Xen gel stent for the surgical management of patients with refractory…

Meeting NewsVideo

VIDEO: Pearls for canal-based microstents in cataract surgery

April 5, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Savak Sev Teymoorian, MD, MBA, of Harvard Eye Associates in Laguna Hills, California…

In the Journals

Ab interno trabeculotomy with Trab360 effective in childhood glaucomas

April 3, 2020
Two-thirds of eyes with childhood glaucomas that underwent ab interno trabeculotomy with the Trab360 device experienced postoperative IOP of 24 mm Hg…

Grand Rounds at the New England Eye Center

Woman presents with elevated IOP

Ocular Surgery News U.S. Edition, April 10, 2020
Chandru Krishnan, MD; Malgorzata Dymerska, MD
A 71-year-old woman was referred to the New England Eye Center for evaluation of elevated IOP in the left eye. Four weeks before presentation, she…

Video

VIDEO: How coronavirus affects glaucoma patient care in a private practice

March 31, 2020
Jason Bacharach, MD, medical director and founding partner at North Bay Eye Associates in the San Francisco Bay area, discusses how he has adjusted…

Perspective

Perspective: I. Paul Singh, MD, on the FDA approval of Durysta

March 26, 2020
The recent paradigm shift in the treatment of glaucoma moving toward earlier intervention, better managing patient compliance and a refocus on…

BlogVideo

BLOG: Single-pass four-throw pupilloplasty for silicone oil-induced glaucoma

March 24, 2020

Meeting NewsVideo

VIDEO: Effective uses of MIGS

March 23, 2020
ORLANDO — At Cataract Surgery: Telling It Like It Is, Inder Paul Singh, MD, discusses the importance of introducing MIGS into practices…

CEDARS/ASPENS Debates

Newer brands, compounded drugs improve efficacy, compliance

Ocular Surgery News U.S. Edition, March 25, 2020
Gary Wörtz, MD; Inder Paul Singh, MD
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to…

Bleb-forming MIGS procedures offer low complication rates

Ocular Surgery News U.S. Edition, March 25, 2020
Presenting glaucoma patients with a minimally invasive approach to lower their IOP with a bleb-forming MIGS procedure can be an appropriate…

Meeting News

Xen ab interno, externo outcomes comparable

March 16, 2020
PHILADELPHIA – Ab interno and ab externo Xen gel stent implantation outcomes were similar with regard to IOP and medication reductions, with…

Meeting News

New eye camp model improves screenings in India

March 11, 2020
WASHINGTON — The use of digital fundus photography in a newly designed model of a Pondicherry eye screening camp better improved case…

Meeting News

Poor medication adherence linked to faster rate of visual field decline

March 10, 2020
WASHINGTON — Patients who better adhered to topical glaucoma medications over time experienced a slower rate of visual field decline compared…

Meeting News

Four AI models show high diagnostic accuracy for glaucoma

March 9, 2020
WASHINGTON — Two conventional machine learning algorithms and two convolutional neural network models achieved high glaucoma diagnostic…

Meeting NewsVideo

VIDEO: Specialist speaks about her experience with new Xen implant in European trial

March 7, 2020
MARRAKECH, Morocco — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Simonetta Morselli, MD, shares her experience…

Meeting News

Understand risk factors to limit endothelial cell loss after glaucoma surgery

March 6, 2020
WASHINGTON — Traditional glaucoma surgery will result in endothelial cell loss, but surgeons can be aware of potential risk factors and take…

Meeting News

Cyclophotocoagulation with trabecular meshwork bypass MIGS may lead to sustained IOP reduction

March 5, 2020
WASHINGTON — Patients with advanced open-angle glaucoma experienced a sustained IOP and medication reduction after undergoing…

FDA News

Biodegradable Durysta approved to lower IOP

March 5, 2020
Durysta, the first intracameral biodegradable sustained-release implant designed to lower IOP in patients with open-angle glaucoma or ocular…

Iridex announces second-generation MicroPulse P3 device

March 5, 2020
Iridex introduced the second generation of the MicroPulse P3 device to deliver greater stability, visualization, coupling and fit when treating…

Meeting News

Glaucoma may be associated with central neurodegenerative diseases

March 5, 2020
WASHINGTON — Patients with glaucoma may have an increased prevalence of certain central neurodegenerative diseases, such as various types of…